Stem cell modified with flexible anti-oxidative stress coating as well as preparation method and application of stem cell
By forming a flexible antioxidant stress coating on the surface of stem cells, and using antioxidant liposome membrane fusion technology, the survival of stem cells in the microenvironment of brain diseases is solved, and the treatment of brain diseases is improved. Healing effects and biological functions.
Patent Information
- Application Number
- CN202411116754.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-14
- Publication Date
- 2024-11-22
AI Technical Summary
Stem cells face high levels of oxidative stress in brain disease microenvironment, leading to survival challenges and inhibition of therapeutic functions. Existing protective methods affect their mechanical properties and deformation capabilities, and there are cytotoxicity and stability problems.
By preparing liposomes with antioxidant stress function, the surface of stem cells is modified to form a flexible antioxidant stress coating, and the specific molar ratio of DOPE and DOTAP and antioxidant groups such as TEMPO are used to achieve membrane fusion and improve stem cells' oxidative response intense resistance.
Without changing the mechanical properties and deformation ability of stem cells, it significantly improves its resistance in the oxidative stress environment, enhances therapeutic ability and targeting function, reduces apoptosis and ROS levels, improves paracrine and migration ability, and enhances the ability to achieve paracrine and migration. Treatment effect.
Smart Images

Figure CN118987272A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of stem cell therapy, and in particular to a stem cell modified with a flexible anti-oxidative stress coating, and a preparation method and application thereof. Background Art
[0002] Brain diseases are one of the main causes of harm to people's lives and health in the current social environment. Among them, stroke, which has the characteristics of high incidence, high disability rate and high mortality rate, has become the leading cause of death among Chinese residents. Its incidence rate is increasing at a rate of 8.3% year by year, which has greatly affected people's lives, health and quality of life.
[0003] Most brain diseases are accompanied by severe oxidative stress and the release of inflammatory factors. For example, in the early stages of ischemic stroke, energy depletion, ion imbalance, and the production of excitatory neurotransmitters in the brain will continue to accumulate damage, and then enter the acute phase. The brain endothelial cells that constitute the blood-brain barrier and the tight junctions on them are destroyed, and the edema gradually worsens. Subsequently, a large number of inflammatory factors are released, oxidative free radicals accumulate excessively in the lesion area, and oxidative stress damage triggers neuronal damage and apoptosis, forming a harsh disease microenvironment.
[0004] In recent years, stem cell transplantation has been widely studied in the treatment of various brain diseases. For example, Wu Honghui et al. mentioned in their research progress on stem cells as gene carriers for targeted treatment of ischemic stroke (Wu Honghui, Xu Donghang, Gao Jianqing. Research progress on stem cells as gene carriers for targeted treatment of ischemic stroke [J]. Chinese Pharmaceutical Journal, 2023, 58(9): 762-770. DOI: 10.11669 / cpj.2023.09.002.) that "stem cell transplantation therapy has performed well in the treatment of brain diseases. In addition to its own repair effect, stem cells can also be used as targeted delivery carriers of drugs / genes to regulate the disease microenvironment after stroke and promote neural regeneration"; however, the high level of oxidative stress in the disease microenvironment poses a huge challenge to the survival of stem cells, thereby inhibiting the therapeutic function of stem cells.
[0005] At present, the main way to protect stem cells in the disease microenvironment is to form a coating on the surface of stem cells through layer-by-layer coating technology to isolate the communication between stem cells and the microenvironment. This coating affects the natural targeting function of stem cells to the damaged brain area by shielding the migration proteins on the surface of stem cells, and may also change the mechanical properties of stem cells, thereby interfering with their ability to deform and cross the blood-brain barrier.
[0006] In addition, the microenvironment can be resisted or alleviated by connecting cells to drug-loaded nanoparticles in the form of "cell backpacks". However, "cell backpacks" require strong reducing agents to expose the connection sites, have greater cytotoxicity, and the stability of the connection is questionable. Therefore, without changing the mechanical properties and deformation ability of stem cells, improving the resistance of stem cells to the high oxidative stress microenvironment of ischemic stroke has good application prospects and important scientific significance for its targeted treatment of ischemic stroke. Summary of the invention
[0007] In view of the shortcomings currently existing in the art, the present invention provides a stem cell modified with a flexible anti-oxidative stress coating, and a preparation method and application thereof. By modifying stem cells with a liposome coating having an anti-oxidative stress function, stem cells are modified without increasing the mechanical properties of stem cells, thereby improving their resistance to high levels of oxidative stress in a harsh disease microenvironment.
[0008] In order to achieve the above purpose, the specific technical scheme is as follows:
[0009] The present invention provides a coating preparation method and application for improving the resistance of stem cells to oxidative stress and maintaining the mechanical properties and deformation ability of stem cells.
[0010] In one aspect, the present invention provides a method for preparing stem cells modified with a flexible anti-oxidative stress coating, comprising the following steps:
[0011] (1) preparing liposomes with anti-oxidative stress function, wherein the molar ratio of DOPE to DOTAP in the liposomes is 1:0.25-4; too large or too small a ratio will lose the ability to fuse with the cell membrane;
[0012] (2) co-incubating liposomes with anti-oxidative stress function with stem cells to obtain stem cells modified with a flexible anti-oxidative stress coating;
[0013] During the co-incubation, the concentration of the liposomes having the anti-oxidative stress function is 50-1000 μg / mL.
[0014] If the incubation concentration is too low, it is not enough to achieve the effect of anti-oxidative stress.
[0015] Specifically, the liposomes with anti-oxidative stress function are prepared by mixing the following materials: dioleoylphosphatidylethanolamine (DOPE), (2,3-dioleyloxypropyl)trimethylammonium chloride (DOTAP), DOPE-PEG (polyethylene glycol)-FITC, and DOPE-PEG-R1;
[0016] Wherein, R1 is an antioxidant group.
[0017] Preferably, the antioxidant group is at least one of the following: 2,2,6,6-tetramethylpiperidin-1-oxyl free radical (TEMPO), 2,2,6,6-tetramethylpiperidin (TEMP), 5,5-dimethyl-1-pyrroline-N-oxide (DMPO).
[0018] In the embodiment of the present invention, TEMPO is selected as an antioxidant group as an example. Other antioxidant groups have the same functional groups and can also achieve the antioxidant technical effect of the present invention.
[0019] Preferably, in the embodiment of the present invention, the molar ratio of DOPE to DOTAP in the liposome is selected as 1:2 as an example, which has excellent antioxidant DPPH elimination ability and cell protection effect, but is not limited thereto.
[0020] Specifically, the DOPE-PEG-R1 is obtained by the reverse amidation reaction of DOPE-PEG-NHS (N-hydroxysuccinimide ester) and amino R1.
[0021] Specific preparation method: DOPE-PEG-NHS is dissolved in N,N-dimethylformamide (DMF), amino R1 and triethylamine are added, and the reaction is carried out at room temperature for 0.5 hours. The product is then dropped into a large amount of icy ether for precipitation, filtered, the product is collected, and vacuum dried to obtain DOPE-PEG-R1.
[0022] Specifically, the stem cells are at least one of the following: umbilical cord-derived mesenchymal stem cells, placenta-derived mesenchymal stem cells, bone marrow-derived mesenchymal stem cells, neural stem cells, induced pluripotent stem cells, and dental pulp stem cells.
[0023] Preferably, the co-incubation condition is incubation at 37° C. for 10-60 min. Too short an incubation time will result in a low fusion number, and further extension of the incubation time will not increase the fusion number.
[0024] The present invention is also applicable to improving the anti-oxidative stress capacity of other cells.
[0025] On the other hand, the present invention also provides stem cells modified with a flexible anti-oxidative stress coating prepared by the preparation method.
[0026] The present invention also provides the use of the stem cells modified with a flexible anti-oxidative stress coating in the preparation of drugs for treating brain-related diseases.
[0027] Preferably, the brain-related disease is ischemic stroke, traumatic brain injury, multiple sclerosis, Alzheimer's disease, Parkinson's disease and the like.
[0028] Compared with the prior art, the present invention has the following beneficial effects:
[0029] (1) The present invention can obtain anti-oxidative stress liposomes with excellent membrane fusion ability by simply optimizing the DOTAP ratio.
[0030] (2) The antioxidant stress liposomes formed by the present invention are prepared by a thin film dispersion method, which has simple steps and operations. The obtained antioxidant stress liposomes have uniform particle size, good PDI, and a wide range of modifiability, including but not limited to TEMPO, TEMP, and DMPO.
[0031] (3) The present invention realizes an antioxidant coating through membrane fusion. Compared with the protection method in the form of "gel coating", it can achieve the goal of not changing the mechanical properties and deformation ability of stem cells, so that they can reach the lesion normally.
[0032] (4) The present invention realizes an antioxidant coating through membrane fusion, which has better stability than the protection method in the form of "hydrophobic insertion" antioxidant groups.
[0033] (5) The present invention realizes an antioxidant coating through membrane fusion, which has better biocompatibility than the protection method that requires treating cells with chemical reagents to expose chemical sites to achieve the "cell backpack" form.
[0034] (6) The stem cells with anti-oxidative stress function formed by the present invention do not affect the normal migration of stem cells and show the same in vivo lesion targeting ability.
[0035] (7) The stem cells with anti-oxidative stress function formed by the present invention do not affect the normal proliferation of stem cells and show the same proliferation ability.
[0036] (8) The stem cells with anti-oxidative stress function formed by the present invention improve the paracrine ability of stem cells and enhance the cell therapeutic ability.
[0037] (9) The stem cells with anti-oxidative stress function formed by the present invention can resist the highly active oxygen microenvironment without the need for additional drugs. BRIEF DESCRIPTION OF THE DRAWINGS
[0038] Figure 1 The graph shows the interaction between liposomes with different DOTAP ratios and stem cells, Bar=20 μm.
[0039] Figure 2 Characterization of anti-oxidative stress liposomes; wherein, A is the particle size range, B is the particle diameter and polymer dispersibility index, and C is the antioxidant DPPH elimination ability of anti-oxidative stress liposomes of different concentrations.
[0040] Figure 3The behavior of stem cells modified with flexible anti-oxidative stress coating (AR-MSC) relative to MSC under oxidative stress environment; A is the cell survival rate after 18 hours of oxidative treatment; B is the apoptosis rate after 18 hours of oxidative treatment; C is the intracellular ROS level after 18 hours of oxidative treatment; ** indicates p < 0.01, *** indicates p < 0.001, **** indicates p < 0.0001.
[0041] Figure 4 The changes in mechanical properties of AR-MSC relative to MSC; A, B, C are the time required to pass through the slit, elongation ratio and passing rate; ns means p>0.05, * means p<0.5, ** means p<0.01, *** means p<0.001.
[0042] Figure 5 The changes in the paracrine function of AR-MSC relative to MSC; A represents the level of the paracrine factor BDNF, B represents the level of the paracrine factor HGF; *** represents p < 0.001, **** represents p < 0.0001.
[0043] Figure 6 The changes in the migration ability of AR-MSC relative to MSC; A represents the changes in the migration ability at the cell level; B represents the changes in the migration ability at the animal level.
[0044] Figure 7 The changes in the therapeutic ability of AR-MSC relative to MSC on ischemic stroke mice; A represents behavioral images, B represents survival statistics, and C represents neurological scores. DETAILED DESCRIPTION
[0045] Example 1: Screening of lipid material ratios and synthesis of anti-oxidative stress liposomes
[0046] 1.1 Screening and preparation of liposomes with membrane fusion ability
[0047] The three lipids DOPE, DOTAP, and DOPE-PEG-FITC were weighed and mixed at a molar ratio of 1:0.25:0.1, 1:2:0.1, and 1:4:0.1, respectively, and then dissolved with an appropriate amount of anhydrous ethanol. The organic solvent was evaporated and removed by a rotary evaporator in a 40°C water bath to form a lipid film. The lipid film was resuspended with an appropriate amount of ultrapure water, and ultrasonicated for 10 minutes at 10% ultrasonic power using an ultrasonic cell crusher to finally prepare liposomes with a molar ratio of DOPE to DOTAP of 1:0.25, 1:2, and 1:4. After incubating each of them with human placenta-derived mesenchymal stem cells at 37°C for 30 minutes, a confocal microscope was used to observe the interaction between each of them and the cells. Figure 1 As shown, the liposomes showed excellent membrane fusion ability.
[0048] 1.2 Synthesis of anti-oxidative stress liposomes
[0049] It mainly includes the following two steps:
[0050] (1) Synthesis of antioxidant unit structure
[0051] The synthesis of DOPE-PEG-TEMPO includes the following steps:
[0052] Weigh 100 mg DOPE-PEG-NHS and dissolve it in 3 mL DMF, add amino TEMPO (1.0 eq.) and triethylamine (3.0 eq.) to dissolve completely, react at room temperature for 0.5 h, and after the reaction, drop the product into a large amount of ice ether for precipitation, filter with a sand core funnel, collect the product, and vacuum dry to obtain DOPE-PEG-TEMPO. The product was characterized by H NMR and IR.
[0053] (2) Synthesis of anti-oxidative stress liposomes
[0054] The three lipids DOPE, DOTAP, and DOPE-PEG-TEMPO were weighed and mixed in a ratio of 1:2:0.1, and then dissolved in an appropriate amount of anhydrous ethanol. The organic solvent was evaporated by a rotary evaporator at 40°C to form a lipid film. The lipid film was resuspended in an appropriate amount of ultrapure water, and ultrasonicated at 10% ultrasonic power for 10 minutes using an ultrasonic cell crusher to obtain anti-oxidative stress liposomes. Figure 2 As shown, the particle size is about 100 nm, the distribution is uniform, the dispersion coefficient is good, and it has excellent antioxidant DPPH elimination ability.
[0055] Example 2: Anti-oxidative stress coating achieves excellent cell protection
[0056] 2.1 Antioxidant stress coating improves cell activity
[0057] Human placenta-derived mesenchymal stem cells were plated at 2×10 per well. 4 The number of liposomes prepared in Example 1 was plated in a 48-well plate. The anti-oxidative stress liposomes prepared in Example 1 were incubated with human placenta-derived mesenchymal stem cells at a concentration of 100 μg / mL for 30 min, and washed three times with PBS to prepare AR-MSC. Serum-free culture medium containing H2O2 (200 μM) was added to stimulate MSC or AR-MSC for 18 h, and the cell survival rate was measured by CCK8 assay after reaching the time point. Figure 3 As shown in A, AR-MSCs showed improved cell activity compared to MSCs.
[0058] 2.2 Antioxidant stress coating reduces cell apoptosis
[0059] Human placenta-derived mesenchymal stem cells were plated at 2×10 per well. 5 The number of seeds was plated in a 6-well plate. AR-MSCs were prepared according to the second step of Example 2.1. Serum-free culture medium containing H2O2 (200 μM) was added to stimulate MSCs or AR-MSCs. After 18 hours, the cells were digested with Accutase at room temperature for 5 minutes. When the cells began to round up, they were collected in flow cytometry tubes, washed once with PBS, resuspended in 500 μL Binding Buffer, and 5 μL Annexin V-FITC and 10 μL PI were added to each tube. The cells were incubated at room temperature for 5 minutes and detected by flow cytometry. Figure 3 As shown in B, the apoptosis rate of AR-MSCs was significantly lower than that of MSCs.
[0060] 2.3 Decrease of intracellular ROS under oxidative stress
[0061] Human placenta-derived mesenchymal stem cells were plated at 2×10 per well. 5 The number of cells was plated in a 6-well plate. AR-MSCs were prepared according to the second step of Example 2.1. Serum-free culture medium containing H2O2 (200 μM) was added to stimulate MSCs or AR-MSCs. After 18 hours, DCFH-DA probe staining was performed for 30 minutes and flow cytometry was performed. Figure 3 As shown in C, the intracellular ROS of AR-MSCs was significantly decreased compared with MSCs and was close to the normal level.
[0062] Example 3: Determination of mechanical properties of AR-MSCs
[0063] Human placenta-derived mesenchymal stem cells were plated at 2×10 per well. 5 AR-MSCs were prepared according to the second step of Example 2.1, with a concentration of 1×10 5 Resuspend MSC or AR-MSC at a cell concentration of 100 cells / mL. Take about 8 mL and add it to the sample tube. Apply 100 mbar pressure to the tube through a pressure pump to push the cells into the microfluidic chip and pass through the slit channels with gaps of 10, 12, and 14 μμm. Calculate the time required to pass through the slit, the elongation ratio, and the passing rate. Figure 4 As shown, AR-MSC showed better deformability in all indicators, indicating that the flexible anti-oxidative stress coating can improve the mechanical properties of stem cells and significantly enhance their deformation ability so that they can reach the lesion normally.
[0064] Example 4: Determination of the paracrine capacity of AR-MSCs
[0065] Human placenta-derived mesenchymal stem cells were plated at 2×10 per well. 5The number of cells was plated in a 6-well plate. AR-MSCs were prepared according to the second step of Example 2.1 and cultured in serum-free medium for three days. After reaching the time point, the culture solution was collected and centrifuged at 500g for 10 minutes, and the supernatant was taken for testing. The concentrations were measured by BDNF Elisa kit and HGF Elisa kit, respectively. Figure 5 As shown, AR-MSCs significantly increased the paracrine factors BDNF and HGF compared to MSCs.
[0066] Example 5: Determination of migration ability of AR-MSCs
[0067] 1. Cellular level
[0068] Human placenta-derived mesenchymal stem cells were plated at 2×10 per well. 5 Seed the cells in the 6-well plate in the same number. AR-MSCs were prepared according to the second step of implementation case 2.1. After trypsin digestion and resuspension, they were added to the Transwell chamber, 40,000 (100 μL) per well. 500 μL of BC-T4 culture medium containing 0.1 μg / mL SDF-1α and 0.5% serum was added to the lower chamber of the Transwell. After incubation for 24 hours, the upper chamber was washed twice with PBS, 500 μL of 4% paraformaldehyde was added to the 24-well plate, and the plate was placed in the chamber for fixation for 15 minutes, and then washed twice with PBS. Stain with 1% crystal violet for 12 minutes, wash twice with PBS, and use a cotton swab to scrape the crystal violet in the upper chamber until there is no purple color, and photograph with a 10x microscope. Figure 6 As shown in A, SDF-1α will significantly increase stem cell migration, and there is no difference in the migration number between AR-MSC and MSC, that is, the anti-oxidative stress coating does not affect the migration behavior of stem cells at the cellular level.
[0069] 2. Animal level
[0070] (1) Establishment of middle cerebral artery occlusion (MCAO) model:
[0071] Male C57BL6 mice weighing 20-25 g were selected for MCAO model establishment surgery. The mice were anesthetized with 1% sodium pentobarbital. The mice were fixed on the operating table in a supine position, the middle opening of the neck was made, the muscles and glands were separated, the pulsating common carotid artery was found, the vagus nerve was separated, and the proximal end was ligated after threading. A slipknot was tied at the distal end, and the upper part was clamped with a hemostatic clamp. The scissors made a small opening between the two wires, inserted the thread plug to the hemostatic clamp, tightened the previous slipknot, opened the hemostatic clamp, and continued to push the thread plug in. The thread plug entered the vascular bifurcation about 8-10 mm and stopped when obvious resistance was encountered. The wound was sutured and the mouse was placed on a heating plate to keep warm at 37°C. The thread plug was pulled out after 60 minutes of ischemia and reperfusion was performed.
[0072] (2) Distribution of AR-MSCs in vivo
[0073] AR-MSCs and MSCs were stained with DiD (10 μg / mL) for 20 min and intravenously injected at 3×10 per mouse. 5 After 18 hours, the heart was perfused with PBS, and the brain, heart, liver, spleen, lung, and kidney were taken to capture tissue fluorescence. Figure 6 As shown in B, there is no difference in fluorescence intensity between AR-MSC and MSC in the brain, that is, the anti-oxidative stress coating does not affect the migration behavior of stem cells at the animal level.
[0074] Example 6: Therapeutic ability of AR-MSCs on MCAO mice
[0075] AR-MSC or MSC were injected into MCAO mice on the day of modeling, and neurological scores and survival rate statistics were performed every day for five days. Behavioral images were taken and survival rate curves and neurological score curves were drawn. Figure 7 As shown in A, on the third day, MCAO mice and MSC mice were unable to hold the beam and fell quickly, while AR-MSC mice were able to hold the beam and maintain it for more than 60 seconds, indicating that their limb strength recovered significantly compared with other groups. At the same time, MCAO mice and MSC mice showed hemiplegia on flat ground, while AR-MSC could walk upright to a certain extent, indicating that their limb coordination and body balance were significantly improved. On the seventh day, AR-MSC still showed the best therapeutic effect compared with other groups. Figure 7 As shown in B, MSCs improved the survival rate of MCAO mice to a certain extent, and AR-MSCs significantly improved the survival rate of MCAO mice within 14 days compared with the MSC group. Figure 7 As shown in C, mNSS showed that the AR-MSC group was significantly lower than the other groups, and there were significant differences with the MSC group on days 4, 5, and 6 after administration, indicating that its nerve recovery was the best compared with other groups. The results show that AR-MSC has a greatly improved therapeutic ability compared with MSC.
[0076] In summary, the present invention discloses a preparation method and application of a flexible stem cell anti-oxidative stress coating, wherein the coating is achieved by fusing anti-oxidative stress liposomes with stem cell membranes, and the obtained stem cells with anti-oxidative stress function can improve their activity in an oxidative environment. At the same time, the coating significantly improves the deformation performance of stem cells, does not affect their paracrine, migration and other biological functions, and ensures their targeting and therapeutic capabilities.
[0077] The embodiments described above provide a detailed description of the technical solutions and beneficial effects of the present invention. It should be understood that the above are only specific embodiments of the present invention and are not intended to limit the present invention. Any modifications, supplements and equivalent substitutions made within the scope of the principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A method for preparing stem cells modified with a flexible anti-oxidative stress coating, characterized in that: The following steps are involved: (1) preparing liposomes with anti-oxidative stress function; The molar ratio of DOPE to DOTAP in the liposome is 1:0.25-4; (2) co-incubating liposomes with anti-oxidative stress function with stem cells to obtain stem cells modified with a flexible anti-oxidative stress coating; During the co-incubation, the concentration of the liposomes having the anti-oxidative stress function is 50-1000 μg / mL.
2. The preparation method according to claim 1, characterized in that: The liposome with anti-oxidative stress function is prepared by mixing the following materials: DOPE, DOTAP, DOPE-PEG-FITC, and DOPE-PEG-R1; Wherein, R1 is an antioxidant group.
3. The preparation method according to claim 2, characterized in that: The antioxidant group is at least one of the following: TEMPO, TEMP, DMPO.
4. The preparation method according to claim 3, characterized in that: The DOPE-PEG-R1 is obtained by the reverse amidation reaction of DOPE-PEG-NHS and amino R1.
5. The preparation method according to claim 1, characterized in that: The stem cells are at least one of the following: umbilical cord-derived mesenchymal stem cells, placenta-derived mesenchymal stem cells, bone marrow-derived mesenchymal stem cells, neural stem cells, induced pluripotent stem cells, and dental pulp stem cells.
6. The preparation method according to claim 1, characterized in that: Incubate at 37°C for 10-60 min.
7. Stem cells modified with a flexible anti-oxidative stress coating prepared by the preparation method according to any one of claims 1 to 6.
8. Use of the stem cells modified with a flexible anti-oxidative stress coating as claimed in claim 7 in the preparation of drugs for treating brain-related diseases.
9. The use according to claim 8, characterized in that: The brain-related disease is ischemic stroke, traumatic brain injury, multiple sclerosis, Alzheimer's disease or Parkinson's disease.
